相似文献
1
Immunology of infection with the human immunodeficiency virus.
Recenti Prog Med. 1988 Jul-Aug;79(7-8):330-7.
2
Immunology in AIDS in 1990.
AIDS. 1990;4 Suppl 1:S9-14.
3
HIV/AIDS vaccines: 2007.
Clin Pharmacol Ther. 2007 Dec;82(6):686-93. doi: 10.1038/sj.clpt.6100408. Epub 2007 Oct 31.
4
Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Expert Rev Vaccines. 2006 Aug;5(4):505-16. doi: 10.1586/14760584.5.4.505.
5
Lymphocyte subsets and abnormalities in retrovirally infected mice.
Crit Rev Immunol. 1990;10(2):73-112.
6
[Polyclonal B cell activation in infection caused by human immunodeficiency virus (HIV)].
Schweiz Med Wochenschr. 1987 Nov 21;117(47):1863-5.
7
AIDS vaccines: back to 'plan A'.
Nature. 2003 Jun 26;423(6943):912-4. doi: 10.1038/423912a.
8
A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
Virology. 2000 Jun 20;272(1):112-26. doi: 10.1006/viro.2000.0333.
9
Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.
Nature. 1993 Jun 3;363(6428):464-6. doi: 10.1038/363464a0.
10
[The infection and immunity of HIV: hope and thought].
Zhonghua Yi Xue Za Zhi. 2007 Jan 23;87(4):220-2.
Zotero 插件